Baylor College of Medicine News

Cancer News

Baylor College of Medicine receives $822,000 in Komen grants Sep 22, 2015
Researchers from the NCI-Comprehensive Designated Dan L. Duncan Cancer Center at Baylor College of Medicine have received over $822,000 in grant funding from Susan G. Komen for four new projects in breast cancer research.
New microsurgery for early stage GI cancer patientsSep 17, 2015
A new endoscopic microsurgery known as endoscopic submucosal dissection (ESD), offers a non-invasive approach to removing small gastrointestinal tumors by removing them in layers.
Baylor research team joins NCI consortium aimed at finding new therapies for children’s cancerSep 15, 2015
Baylor one of five groups to receive a National Cancer Institute grant to address key challenges in developing new therapies for children with cancer.
Baylor College of Medicine receives grant to study experimental immunotherapy in HPV-related throat cancerSep 14, 2015
Baylor researchers receive $1.1 million grant from the U.S. Food and Drug Administration to advance clinical studies of an experimental immunotherapy for HPV related throat cancer.
Cycle for a cureSep 9, 2015
Baylor teaming up with Ovarian Cancer Research Fund for Sept. 19 Ovarian Cycle Houston event.
Curley awarded $9 million grant to study radiofrequency treatments for pancreatic and liver cancersSep 9, 2015
Dr. Steven Curley and his research team will study radiofrequency energy to treat cancer alone or in combination with drugs and treatment-enhancing agents such as nanoparticles.
Disruption of a crucial cellular machine may kill the engine of deadly cancersSep 2, 2015
Baylor College of Medicine study finds that inhibition of the spliceosome using a new drug kills tumor cells but leaves noncancerous tissues unaffected in mouse models.
Electronic trigger reduces delays in evaluation for cancer diagnosisAug 24, 2015
Electronic triggers designed to search for key data were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.
Super-stimulation makes SRCs cancer cell killersAug 10, 2015
Too much of a bad thing could have a positive effect – especially when there is too much of a master cell regulator and a small molecule that can make it a cancer fighter, said Baylor College of Medicine researchers.
Baylor’s Dan L. Duncan Cancer Center receives highest National Cancer Institute designation – Comprehensive statusJul 30, 2015
The National Cancer Institute has awarded the Dan L. Duncan Cancer Center at Baylor College of Medicine the prestigious designation of a Comprehensive Cancer Center.